← Evidence map

ArticleEMBO molecular medicine2018

Tranilast directly targets NLRP3 to treat inflammasome-driven diseases.

Yi Huang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

290 papers cite itlatest 60 shown

2018
…
2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 29531021